Percutaneous coronary intervention Glycoprotein IIb/IIIa Receptor Antagonists
Percutaneous Coronary Intervention Guidelines Microchapters |
PCI Approaches: |
---|
CAD Revascularization: |
Pre-procedural Considerations: |
Procedural Considerations: |
|
|
|
|
|
|
|
|
|
Post-Procedural Considerations: |
Quality and Performance Considerations: |
Percutaneous coronary intervention Glycoprotein IIb/IIIa Receptor Antagonists On the Web |
American Roentgen Ray Society Images of Percutaneous coronary intervention Glycoprotein IIb/IIIa Receptor Antagonists |
FDA on Percutaneous coronary intervention Glycoprotein IIb/IIIa Receptor Antagonists |
CDC on Percutaneous coronary intervention Glycoprotein IIb/IIIa Receptor Antagonists |
Percutaneous coronary intervention Glycoprotein IIb/IIIa Receptor Antagonists in the news |
Blogs on Percutaneous coronary intervention Glycoprotein IIb/IIIa Receptor Antagonists |
Directions to Hospitals Treating Percutaneous Coronary Intervention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) -Recommendations for the Use of Glycoprotein IIb/IIIa Receptor Antagonists[1] (DO NOT EDIT)
Class IIa |
"1.It is reasonable to start treatment with glycoprotein IIb/IIIa receptor antagonists (abciximab9,(Level of Evidence: B),tirofiban11,(Level of Evidence: B)or eptifibatide (Level of Evidence: B)at the time of primary PCI (with or without stenting) in selected patients with STEMI." |
Class IIa |
"1.The usefulness of glycoprotein IIb/IIIa receptor antagonists (as part of a preparatory pharmacological strategy for patients with STEMI before their arrival in the cardiac catheterization laboratory for angiography and PCI) is uncertain. (Level of Evidence: B)" |
References
- ↑ Kushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE, Green LA, Hochman JS, Jacobs AK, Krumholz HM, Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MA, Whitlow PL, Williams DO (2009). "2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Journal of the American College of Cardiology. 54 (23): 2205–41. doi:10.1016/j.jacc.2009.10.015. PMID 19942100. Retrieved 2011-12-06. Unknown parameter
|month=
ignored (help)